J. Maris, M. Hogarty, R. Bagatell, S. Cohn, and . Neuroblastoma, Neuroblastoma, The Lancet, vol.369, issue.9579, pp.2106-2126, 2007.
DOI : 10.1016/S0140-6736(07)60983-0

J. Maris and K. Matthay, Molecular Biology of Neuroblastoma, Journal of Clinical Oncology, vol.17, issue.7, pp.2264-79, 1999.
DOI : 10.1200/JCO.1999.17.7.2264

T. Efferth, Willmar Schwabe Award 2006: Antiplasmodial and Antitumor Activity of Artemisinin - From Bench to Bedside, Planta Medica, vol.73, issue.4, pp.299-309, 2007.
DOI : 10.1055/s-2007-967138

H. Woerdenbag, T. Moskal, N. Pras, T. Malingré, F. Feraly et al., Cytotoxicity of Artemisinin-Related Endoperoxides to Ehrlich Ascites Tumor Cells, Journal of Natural Products, vol.56, issue.6, pp.849-56, 1993.
DOI : 10.1021/np50096a007

A. Beekman, A. Barentsen, H. Woerdenbag, W. Van-uden, N. Pras et al., Stereochemistry-Dependent Cytotoxicity of Some Artemisinin Derivatives, Journal of Natural Products, vol.60, issue.4, pp.325-355, 1997.
DOI : 10.1021/np9605495

A. Beekman, P. Wierenga, H. Woerdenbag, W. Van-uden, N. Pras et al., Artemisinin-Derived Sesquiterpene Lactones as Potential Antitumour Compounds: Cytotoxic Action against Bone Marrow and Tumour Cells, Planta Medica, vol.64, issue.07, pp.615-624, 1998.
DOI : 10.1055/s-2006-957533

T. Efferth, A. Olbrich, and R. Bauer, mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether, Biochemical Pharmacology, vol.64, issue.4, pp.617-640, 2002.
DOI : 10.1016/S0006-2952(02)01221-2

T. Efferth, A. Sauerbrey, A. Olbrich, E. Gebhart, P. Rauch et al., Molecular Modes of Action of Artesunate in Tumor Cell Lines, Molecular Pharmacology, vol.64, issue.2, pp.382-94, 2003.
DOI : 10.1124/mol.64.2.382

M. Youns, T. Efferth, J. Reichling, K. Fellenberg, A. Bauer et al., Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells, Biochemical Pharmacology, vol.78, issue.3, pp.273-83, 2009.
DOI : 10.1016/j.bcp.2009.04.014

URL : https://hal.archives-ouvertes.fr/hal-00493519

T. Efferth, M. Davey, A. Olbrich, G. Rücker, E. Gebhart et al., Activity of Drugs from Traditional Chinese Medicine toward Sensitive and MDR1- or MRP1-Overexpressing Multidrug-Resistant Human CCRF-CEM Leukemia Cells, Blood Cells, Molecules, and Diseases, vol.28, issue.2, pp.160-168, 2002.
DOI : 10.1006/bcmd.2002.0492

J. Hou, D. Wang, R. Zhang, and H. Wang, Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action, Clinical Cancer Research, vol.14, issue.17, pp.5519-5549, 2008.
DOI : 10.1158/1078-0432.CCR-08-0197

R. Kotchetkov, P. Driever, J. Cinatl, M. Michaelis, J. Karaskova et al., Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression, International Journal of Oncology, vol.27, pp.1029-1066, 2005.
DOI : 10.3892/ijo.27.4.1029

M. Michaelis, I. Fichtner, D. Behrens, W. Haider, F. Rothweiler et al., Anticancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo, Int J Oncol, vol.28, pp.439-485, 2006.

M. Michaelis, J. Cinatl, P. Anand, F. Rothweiler, R. Kotchetkov et al., Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells, Cancer Letters, vol.250, issue.1, pp.107-123, 2007.
DOI : 10.1016/j.canlet.2006.09.018

M. Michaelis, F. Rothweiler, D. Klassert, A. Von-deimling, K. Weber et al., Reversal of P-glycoprotein-Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3, Cancer Research, vol.69, issue.2, pp.416-437, 2009.
DOI : 10.1158/0008-5472.CAN-08-1856

B. Bolstad, R. Irizarry, M. Astrand, and T. Speed, A comparison of normalization methods for high density oligonucleotide array data based on variance and bias, Bioinformatics, vol.19, issue.2, pp.185-93, 2003.
DOI : 10.1093/bioinformatics/19.2.185

T. Efferth and M. Volm, Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate, In Vivo, vol.19, pp.225-257, 2005.

L. Anfosso, T. Efferth, A. Albini, and U. Pfeffer, Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins, The Pharmacogenomics Journal, vol.18
DOI : 10.1038/sj.tpj.6500371

C. Huang, L. Chang, M. Anderson, and A. Meister, Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase, J Biol Chem, vol.268, pp.19675-80, 1993.

C. Huang, M. Anderson, and A. Meister, Amino acid sequence and function of the light subunit of rat kidney gamma-glutamylcysteine synthetase, J Biol Chem, vol.268, pp.20578-83, 1993.

C. Huang, W. He, A. Meister, and M. Anderson, Amino acid sequence of rat kidney glutathione synthetase., Proceedings of the National Academy of Sciences, vol.92, issue.4, pp.1232-1238, 1995.
DOI : 10.1073/pnas.92.4.1232

Y. Yang, M. Dieter, Y. Chen, H. Shertzer, D. Nebert et al., Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(-/-) Knockout Mouse. NOVEL MODEL SYSTEM FOR A SEVERELY COMPROMISED OXIDATIVE STRESS RESPONSE, Journal of Biological Chemistry, vol.277, issue.51, pp.49446-52, 2002.
DOI : 10.1074/jbc.M209372200

T. Efferth, M. Giaisi, A. Merling, P. Krammer, and M. Li-weber, Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells, PLoS ONE, vol.7, issue.8, p.693, 2007.
DOI : 10.1371/journal.pone.0000693.g005

M. Circu and T. Aw, Glutathione and apoptosis, Free Radical Research, vol.371, issue.3, pp.689-706, 2008.
DOI : 10.1074/jbc.M312722200

K. Batty, T. Davis, L. Thu, T. Binh, T. Anh et al., Selective high-performance liquid chromatographic determination of artesunate and ??- and ??-dihydroartemisinin in patients with falciparum malaria, Journal of Chromatography B: Biomedical Sciences and Applications, vol.677, issue.2, pp.345-50, 1996.
DOI : 10.1016/0378-4347(95)00428-9

P. Li, E. Lam, W. Roos, M. Zdzienicka, B. Kaina et al., Artesunate Derived from Traditional Chinese Medicine Induces DNA Damage and Repair, Cancer Research, vol.68, issue.11, pp.4347-51, 2008.
DOI : 10.1158/0008-5472.CAN-07-2970

Z. Siddik, Cisplatin: mode of cytotoxic action and molecular basis of resistance, Oncogene, vol.22, issue.47
DOI : 10.1038/sj.onc.1206933

J. Biaglow and R. Miller, The thioredoxin reductase/thioredoxin system: Novel redox targets for cancer therapy, Cancer Biology & Therapy, vol.4, issue.1, pp.6-13, 2005.
DOI : 10.4161/cbt.4.1.1434

D. Stewart, Mechanisms of resistance to cisplatin and carboplatin, Critical Reviews in Oncology/Hematology, vol.63, issue.1, pp.12-31, 2007.
DOI : 10.1016/j.critrevonc.2007.02.001

D. Wang and S. Lippard, Cellular processing of platinum anticancer drugs, Nature Reviews Drug Discovery, vol.11, issue.4, pp.307-327, 2005.
DOI : 10.1016/0006-2952(88)90325-5

D. Spitz, J. Phillips, D. Adams, C. Sherman, D. Deen et al., Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: The significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts, Journal of Cellular Physiology, vol.292, issue.1, pp.72-81, 1993.
DOI : 10.1002/jcp.1041560111

T. Sasada, S. Iwata, N. Sato, Y. Kitaoka, K. Hirota et al., Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity., Journal of Clinical Investigation, vol.97, issue.10, pp.2268-76, 1996.
DOI : 10.1172/JCI118668

A. Miyajima, J. Nakashima, K. Yoshioka, M. Tachibana, H. Tazaki et al., Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells, British Journal of Cancer, vol.76, issue.2, pp.206-216, 1997.
DOI : 10.1038/bjc.1997.363

M. Jiang, Q. Wei, N. Pabla, G. Dong, C. Wang et al., Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity, Biochemical Pharmacology, vol.73, issue.9, pp.1499-510, 2007.
DOI : 10.1016/j.bcp.2007.01.010

X. Jing, X. Cai, H. Hu, S. Chen, B. Chen et al., Reactive oxygen species and mitochondrial membrane potential are modulated during CDDP-induced apoptosis in EC-109 cellsThis paper is one of a selection of papers in this Special Issue, entitled International Symposium on Recent Advances in Molecular, Clinical, and Social Medicine, and has undergone the Journal's usual peer-review process., Biochemistry and Cell Biology, vol.85, issue.2, pp.265-71, 2007.
DOI : 10.1139/O07-014